Effective AMD Early Detection

AMD Sensor

The AMD sensor provides information about whether there is a genetic risk for age-related macular degeneration.

Age-dependent macular degeneration is often detected late

It’s quite normal for eyesight to deteriorate with age. For many people, however, the slowly progressive loss of sight is not limited to age-typical limitations. Additional eye diseases often cause vision to suffer far beyond normal levels.

One such disease is age-related macular degeneration (AMD). This eye disease can occur in various forms and leads to a progressive loss of vision in the area of the sharpest sight.

Possible causes of AMD

The exact causes of age-related macular degeneration are still unclear. However, we know that at least three different genes have a significant influence on the probability of developing AMD.

Therefore, genetic analysis can help to determine the individual risk for age-related macular degeneration and to detect symptoms at an early stage.

How our AMD Sensor works

As part of our AMD Sensor, we carry out a genetic analysis in our laboratory. In the sample we send in, we analyze the three genes that can increase the risk of developing age-dependent macular degeneration.

This enables us to determine the individual probability for AMD and to recommend appropriate preventive measures based on the results.

After a successful analysis, we prepare a written report. This contains a precise evaluation of the test results as well as concrete recommendations for the patient.

In this way, our AMD Sensor can make an important contribution to the early detection of age-related macular degeneration and help AMD sufferers to support their vision with the right preventive measures.

The AMD Sensor at a glance:

  • Analysis of three relevant genes
  • Assessment of the risk of developing age-related macular degeneration
  • Reliable examination in our laboratory
  • Written report with all important results
  • Individual recommendations for effective prevention

DNAhealth Control

The DNAhealth Control analyzes are not offered by Novogenia.

These are created and sold by our partner company DNA PLUS - Zentrum für Humangenetik GmbH in Germany.
Science available on genes
Science available on recommendations
PROGRAM BASED ON LOGICAL CONCLUSIONS
CUSTOMER FEEDBACK ON EFFECTIVENESS GIVEN
INTERNAL EXPERIMENTS HAVE PROVEN ITS EFFECTIVENESS
EXTERNAL STUDIES HAVE PROVEN THE EFFECTIVENESS OF THE COMBINED RECOMMENDATION
Further information can be foundhere.

Are you interested in a demo report?

After a successful analysis, we summarize the individual results in a detailed result report. You will also find information on the analyzed genes and the underlying science in this demo.

We would be happy to send you the demo report. Just send us an email with the name of the analysis.

➤ keyaccount@novogenia.com